Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P120016/S043

VASCADE 5F Vascular Closure System

Cardiva Medical, Inc. · Decision date Sep 10, 2026

MEDTECHLEDGER EXPLANATIONP120016/S043

What did the FDA decide?

The FDA recorded decision OK30 on 2026-09-10 for P120016/S043, a 30-Day Notice supplement to the VASCADE 5F Vascular Closure System (Model 700-500DX) held by Cardiva Medical, Inc. The supplement reason is listed as a process change covering manufacturer, sterilizer, packager or supplier. The recorded statement describes an additional supplier for the collagen plug component of the device.

This action concerns the supply arrangement for one component rather than a new approval of the whole system. The device is categorized as a vascular hemostasis device in the cardiovascular specialty under product code MGB. The source record does not identify the added supplier, the site involved, or any supporting documents, and it gives no clinical or performance data; those details remain unknown from this record.

Whether the supplier change affects collagen plug performance or requires further review is not addressed in the available fields, so no clinical or legal conclusion is drawn here.

FDA approval order statement

an additional supplier for the collagen plug component of the VASCADE 5F (Model 700-500DX)
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 10, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P120016/S043
Regulatory pathway
PMA supplement
Product code
MGB
Decision code
OK30
Decision date
Sep 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, hemostasis, vascular.

Product code
MGB
FDA device class
3

For the original device and its historical approval scope, see PMA P120016. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P120016 · Original PMA

    VASCADE VASCULAR CLOSURE SYSTEM

  2. P120016/S043 received

    Application receipt date recorded by FDA.

  3. P120016/S043 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P120016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P120016

Product / regulatory recordCompanyPathwayDecision dateSource
Cardiva Medical, Inc.PMA approvalJan 31, 2013FDA

Explore the linked device profile

Other records with product code MGB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cardiva Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2900 Lakeside Dr., Suite 160, Santa Clara, CA, 95054

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records